Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

CO₂ laser therapy improves skin and hair growth in localized scleroderma without severe side effects.

A new, quick method was developed to analyze skin lipids, discovering a new ceramide subclass.

Clascoterone safely promotes hair growth similar to minoxidil.

BMS-470539 reduces skin fibrosis and inflammation.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Anti-CD19 therapy may help treat SLE and NMOSD.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

LC-OCT can help identify lupus-related scarring hair loss by spotting unique features.

PBMCsec can help reduce and improve thick skin scars.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

The new criteria for classifying lupus are more accurate and comprehensive.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

The new protocol using Cellutome™ and RCM safely assesses wound healing in detail.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

pCLCA2 protein may help maintain skin structure and function.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

AQB reduces harmful skin changes in systemic sclerosis.

The updated criteria improve the accuracy of diagnosing lupus.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.